EGM
AQST icon

Engineers Gate Manager’s Aquestive Therapeutics AQST Stock Holding History

Engineers Gate Manager’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$207K Buy
49,879
+8,496
+21% +$35.8K ﹤0.01% 1951
2026
Q1 		$172K Buy
+41,383
New +$168K ﹤0.01% 1946
2024
Q4 		– Sell
-22,046
Closed -$110K – 2210
2024
Q3 		$110K Sell
22,046
-4,664
-17% -$18.1K ﹤0.01% 1909
2024
Q2 		$69.4K Buy
26,710
+12,650
+90% +$42.3K ﹤0.01% 1782
2024
Q1 		$59.9K Buy
+14,060
New +$46.8K ﹤0.01% 1798
2022
Q3 		– Sell
-18,261
Closed -$12K – 1594
2022
Q2 		$12K Buy
+18,261
New +$24.3K ﹤0.01% 1837
2022
Q1 		– Sell
-37,500
Closed -$146K – 1833
2021
Q4 		$146K Buy
+37,500
New +$188K 0.01% 1737
2021
Q2 		– Sell
-51,200
Closed -$266K – 1587
2021
Q1 		$266K Buy
51,200
+2,200
+4% +$11.7K 0.01% 1398
2020
Q4 		$262K Sell
49,000
-19,300
-28% -$116K 0.01% 1378
2020
Q3 		$332K Buy
68,300
+42,400
+164% +$277K 0.02% 1193
2020
Q2 		$126K Buy
+25,900
New +$119K 0.01% 1542
2020
Q1 		– Sell
-18,400
Closed -$107K – 1548
2019
Q4 		$107K Buy
+18,400
New +$95.7K ﹤0.01% 1538
2019
Q1 		– Sell
-14,161
Closed -$89K – 922
2018
Q4 		$89K Sell
14,161
-12,350
-47% -$156K 0.01% 813
2018
Q3 		$464K Buy
+26,511
New +$437K 0.04% 532

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Engineers Gate Manager's AQST Position: Q2 2026 in Review

Engineers Gate Manager increased its Aquestive Therapeutics (AQST) stake by 21% in Q2 2026, buying an estimated $35.8K and bringing the position to 49,879 shares worth $207K. The position accounts for ﹤0.01% of the portfolio, ranked #1951.

Engineers Gate Manager first reported a position in AQST in Q3 2018 and has held it in 14 quarters since. The position peaked at $464K in Q3 2018. 185 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Engineers Gate Manager held 49,879 shares of Aquestive Therapeutics worth $207K as of Q2 2026.
  • Engineers Gate Manager bought 8,496 Aquestive Therapeutics shares in Q2 2026, an estimated $35.8K.
  • Aquestive Therapeutics made up ﹤0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1951 holding.
  • Engineers Gate Manager first reported a position in Aquestive Therapeutics in Q3 2018 and has held it in 14 quarters since.
  • Engineers Gate Manager's Aquestive Therapeutics position peaked at $464K in Q3 2018.
  • 185 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.